{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:52:23Z","timestamp":1792183943478,"version":"4.4.0"},"reference-count":11,"publisher":"BMJ","issue":"7296","license":[{"start":{"date-parts":[[2001,5,19]],"date-time":"2001-05-19T00:00:00Z","timestamp":990230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[2001,5,19]]},"DOI":"10.1136\/bmj.322.7296.1194","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:43:06Z","timestamp":1027752186000},"page":"1194-1195","source":"Crossref","is-referenced-by-count":19,"title":["Protecting travellers from hepatitis A"],"prefix":"10.1136","volume":"322","author":[{"given":"George","family":"Webster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Dusheiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2001,5,19]]},"reference":[{"key":"2025122109245695000_322.7296.1194.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902253400802"},{"key":"2025122109245695000_322.7296.1194.2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0950268800051529","article-title":"Age-specific antibody prevalence to hepatitis A in England: implications for disease control","volume":"113","author":"Gay","year":"1994","journal-title":"Epidemiol.Infect"},{"key":"2025122109245695000_322.7296.1194.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902253400810"},{"key":"2025122109245695000_322.7296.1194.4","first-page":"192","article-title":"Human normal immunoglobulin for prevention of hepatitis A infection in primary care","volume":"78","author":"Franklin","year":"2000","journal-title":"Vox Sang"},{"key":"2025122109245695000_322.7296.1194.5","first-page":"301","volume":"10","year":"2000","journal-title":"CDR Weekly Report"},{"key":"2025122109245695000_322.7296.1194.6","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/0264-410X(92)90572-2","article-title":"Inactivated hepatitis A vaccine: Active and passive immunoprophylaxis in chimpanzees","volume":"10","author":"Purcell","year":"1992","journal-title":"Vaccine"},{"key":"2025122109245695000_322.7296.1194.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430414"},{"key":"2025122109245695000_322.7296.1194.8","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1996.02170320079014"},{"key":"2025122109245695000_322.7296.1194.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08139-2"},{"key":"2025122109245695000_322.7296.1194.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.309.6959.918"},{"key":"2025122109245695000_322.7296.1194.11","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/0264-410X(92)90548-X","article-title":"Risk of hepatitis A in travellers","volume":"10","author":"Steffen","year":"1992","journal-title":"Vaccine"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.322.7296.1194","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.322.7296.1194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T17:25:04Z","timestamp":1766337904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.322.7296.1194"}},"subtitle":["Vaccine should be used for almost every occasion when prevention is required"],"short-title":[],"issued":{"date-parts":[[2001,5,19]]},"references-count":11,"journal-issue":{"issue":"7296","published-online":{"date-parts":[[2001,5,19]]},"published-print":{"date-parts":[[2001,5,19]]}},"alternative-id":["10.1136\/bmj.322.7296.1194"],"URL":"https:\/\/doi.org\/10.1136\/bmj.322.7296.1194","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,19]]}}}